Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Capital Leases (2017 - 2018)

KalVista Pharmaceuticals' Capital Leases history spans 2 years, with the latest figure at $58000.0 for Q2 2018.

  • For Q2 2018, Capital Leases changed N/A year-over-year to $58000.0; the TTM value through Apr 2018 reached $58000.0, changed N/A, while the annual FY2018 figure was $58000.0, N/A changed from the prior year.
  • Capital Leases for Q2 2018 was $58000.0 at KalVista Pharmaceuticals, down from $117000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $213000.0 in Q3 2017 and bottomed at $58000.0 in Q2 2018.